FDA approves diabetes drug that also helps with weight lossDecember 5, 2017 9:28pm

TRENTON, N.J. (AP) — U.S. regulators on Tuesday approved a new diabetes drug that reduces blood sugar levels and also helps people lose significant weight.

Danish drugmaker Novo Nordisk said the Food and Drug Administration approved its once-a-week shot for people with Type 2 diabetes. The drug, Ozempic, also known as semaglutide, works by stimulating the body's own insulin production and reducing appetite.

In one big company-funded study, Ozempic, on average, reduced long-term blood sugar levels at least 2 ½ times as much as a popular daily diabetes pill, Merck & Co.'s Januvia. It also helped study participants lose two to three times as much weight as those in the comparison group.

Over 56 weeks, patients who got a lower dose of Ozempic lost an average of 9.5 pounds (4.3 kilograms) while those who got a higher dose lost 13.5 pounds (6.1 kilograms). The patients who took Januvia lost an average of 4 pounds (1.9 kilograms).

The 1,200 study participants were also taking one or two standard diabetes medicines.

Novo Nordisk, a leader in diabetes care, has also been testing the drug separately for weight loss alone.

Many Type 2 diabetes patients are overweight or obese, and losing significant weight usually helps them reduce their blood sugar and better control their diabetes. Over time, too high sugar in the blood can damage multiple organs and weaken circulation.

The new drug comes in injector pens and costs about the same as similar weekly drugs: $676 for a four- to six-week supply without insurance. Novo Nordisk already sells a similar once-a-day shot, Victoza.

Ozempic will compete with other popular once-a-week drugs in the same class, including Eli Lilly and Co.'s Trulicity and AstraZeneca PLC's Bydureon, which don't produce as much weight loss. However, they all carry warnings about possible serious side effects, including kidney damage and inflammation of the pancreas. They also may be linked to thyroid cancer, so people taking all drugs in the class are being followed via a patient registry.

Januvia is in a different drug class.

___

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

Page 1 of 1

More Stories Like This

FILE - This 2017 file booking photo provided by the Tooele County Sheriff's Office shows Lyle Jeffs. The former polygamous sect leader was sentenced Wednesday, Dec. 13, 2017, to nearly five years for his role in carrying out an elaborate food stamp fraud scheme and for escaping home confinement while awaiting trial. (Tooele County Sheriffs Office, via AP, File)
Ex-polygamous sect leader gets nearly 5 years in fraud case
Business HighlightsBusiness Highlights
A Value Village store is seen Tuesday, Dec. 12, 2017, in Edmonds, Wash. The company that operates 300 Value Village, Savers and other thrift stores in the U.S., Canada and Australia is suing Washington state Attorney General Bob Ferguson, saying his office has violated its rights by demanding $3.2 million to settle a three-year investigation. (AP Photo/Elaine Thompson)
Value Village sues Washington attorney general over demands
12 governors urge Congress to fund children's health programA dozen governors of both parties are urging Congress to reauthorize funding for a popular children's health insurance program as soon as possible
Gehrig's 1931 contract sold at auction for $216,000Lou Gehrig's 1931 contract with the New York Yankees has sold at auction for $216,000
Exxon says it will increase climate-change disclosuresExxon Mobil says it will disclose more about how climate change could affect its business
This component is currently unavailable.
AdChoices

Related Searches

Related Searches

Most Popular

AdChoices